← FDA DRUG APPROVALS

FDA ANDA · ANDA076886

FOSPHENYTOIN SODIUM

Sponsor: DR REDDYS

APPLICATION
ANDA076886
TYPE
ANDA
ORIGINAL APPROVAL
2007-08-06
LATEST ACTION
2020-12-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FOSPHENYTOIN SODIUMDiscontinued
FOSPHENYTOIN SODIUM EQ 50MG PHENYTOIN NA/ML · INJECTABLE · INJECTION

Approval history

2020-12-17Labeling · Supplement 9 · standardAP
2020-12-17Labeling · Supplement 10 · standardAP
2020-12-17Labeling · Supplement 11 · standardAP
2007-08-06OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →